Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy

Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy

Targeting altered tumour metabolism is an emerging therapeutic strategy for cancer treatment. The metabolic reprogramming that accompanies the development of malignancy creates targetable differences between cancer cells and normal cells, which may be exploited for therapy. There is also emerging ev...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Jiaqi Li, Jie Qing Eu, Li Ren Kong, Lingzhi Wang, Yaw Chyn Lim, Boon Cher Goh, Andrea L. A. Wong
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	MDPI AG 2020-10-01
Sraith:	Molecules
Ábhair:	cancer cell metabolism tumour microenvironment metabolic reprogramming targeted therapy immunotherapy
Rochtain ar líne:	https://www.mdpi.com/1420-3049/25/20/4831

Míreanna comhchosúla

Mitochondrial Retrograde Signalling and Metabolic Alterations in the Tumour Microenvironment
de réir: Dongki Yang, et al.
Foilsithe / Cruthaithe: (2019-03-01)

Metabolism, metabolites, and macrophages in cancer
de réir: Mengyuan Li, et al.
Foilsithe / Cruthaithe: (2023-07-01)

Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy
de réir: Yi Lin, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Targeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumour microenvironment
de réir: Mary B Mockler, et al.
Foilsithe / Cruthaithe: (2014-05-01)

Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment
de réir: Haixia Zhang, et al.
Foilsithe / Cruthaithe: (2024-09-01)

Autonomous glucose metabolic reprogramming of tumour cells under hypoxia: opportunities for targeted therapy
de réir: Mingyao Huang, et al.
Foilsithe / Cruthaithe: (2020-09-01)

Advances in macrophage and T cell metabolic reprogramming and immunotherapy in the tumor microenvironment
de réir: Hua Cheng, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Glucose metabolism and tumour microenvironment in pancreatic cancer: A key link in cancer progression
de réir: Shi Dong, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment
de réir: Yifei Zhu, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Lighting Up the Fire in the Microenvironment of Cold Tumors: A Major Challenge to Improve Cancer Immunotherapy
de réir: Alice Benoit, et al.
Foilsithe / Cruthaithe: (2023-07-01)

Unlocking the potential of T‐cell metabolism reprogramming: Advancing single‐cell approaches for precision immunotherapy in tumour immunity
de réir: Lihaoyun Huang, et al.
Foilsithe / Cruthaithe: (2024-03-01)

Analyzing the impact of metabolism on immune cells in tumor microenvironment to promote the development of immunotherapy
de réir: Yanru Long, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics
de réir: Soumik Pal, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Identification of a novel lipid metabolism-related gene signature within the tumour immune microenvironment for breast cancer
de réir: Xu Chang, et al.
Foilsithe / Cruthaithe: (2022-05-01)

Mechanisms of HIF-driven immunosuppression in tumour microenvironment
de réir: Shinjini Bandopadhyay, et al.
Foilsithe / Cruthaithe: (2023-08-01)

The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy
de réir: Dongming Li, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Metabolic reprogramming and immunological changes in the microenvironment of esophageal cancer: future directions and prospects
de réir: Zhi-Xun Guo, et al.
Foilsithe / Cruthaithe: (2025-01-01)

Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy
de réir: Ming Zhang, et al.
Foilsithe / Cruthaithe: (2022-09-01)

Glycolysis in the tumor microenvironment: a driver of cancer progression and a promising therapeutic target
de réir: Junpeng Zhao, et al.
Foilsithe / Cruthaithe: (2024-06-01)

Fine-Tuning the Tumour Microenvironment: Current Perspectives on the Mechanisms of Tumour Immunosuppression
de réir: Jesse D. Armitage, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Effect of neoadjuvant chemotherapy on the immune microenvironment of gynaecological tumours
de réir: Jing Xue, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy
de réir: Di Chen, et al.
Foilsithe / Cruthaithe: (2024-09-01)

A signature based on circadian rhythm-associated genes for the evaluation of prognosis and the tumour microenvironment in HNSCC
de réir: Changqian Wang, et al.
Foilsithe / Cruthaithe: (2024-03-01)

Editorial: Molecular biomarkers and imaging markers in the prediction, diagnosis, and prognosis of bladder cancer
de réir: Yongwen Luo, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Advances in reprogramming of energy metabolism in tumor T cells
de réir: Liu Xuekai, et al.
Foilsithe / Cruthaithe: (2024-02-01)

Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy
de réir: Andrea Nicolini, et al.
Foilsithe / Cruthaithe: (2024-07-01)

Bicarbonate transport as regulator of antitumour immunity in pancreatic cancer
de réir: Emily J. Kay, et al.
Foilsithe / Cruthaithe: (2023-04-01)

Nanomedicines Targeting Metabolism in the Tumor Microenvironment
de réir: Mengdi Ren, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Editorial: Tumor metabolic microenvironment: one man’s meat is another man’s poison
de réir: Jing Xu, et al.
Foilsithe / Cruthaithe: (2024-05-01)

Targeting tumour microenvironment by tyrosine kinase inhibitor
de réir: Hor-Yue Tan, et al.
Foilsithe / Cruthaithe: (2018-02-01)

m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion
de réir: Xiaoxue Cao, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Choline metabolism reprogramming mediates an immunosuppressive microenvironment in non-small cell lung cancer (NSCLC) by promoting tumor-associated macrophage functional polarization and endothelial cell proliferation
de réir: Bijing Xiao, et al.
Foilsithe / Cruthaithe: (2024-05-01)

High-ammonia microenvironment promotes stemness and metastatic potential in hepatocellular carcinoma through metabolic reprogramming
de réir: Renchao Zou, et al.
Foilsithe / Cruthaithe: (2025-02-01)

Editorial: Tumor microenvironment and metabolic reprogramming in cancer
de réir: Xiaoling Cui, et al.
Foilsithe / Cruthaithe: (2024-10-01)

Metabolic reprogramming in the tumor microenvironment of liver cancer
de réir: Jian Lin, et al.
Foilsithe / Cruthaithe: (2024-01-01)

LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling
de réir: Jianhang Jiao, et al.
Foilsithe / Cruthaithe: (2024-10-01)

Macrophage metabolic reprogramming and atherosclerotic plaque microenvironment: Fostering each other?
de réir: Qi Xiao, et al.
Foilsithe / Cruthaithe: (2023-05-01)

A review of lactate-lactylation in malignancy: its potential in immunotherapy
de réir: Jinhui Zha, et al.
Foilsithe / Cruthaithe: (2024-05-01)

Molecular characteristics and immune microenvironment of gastrointestinal stromal tumours: targets for therapeutic strategies
de réir: Yang Yu, et al.
Foilsithe / Cruthaithe: (2024-07-01)

Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review
de réir: Xingtao Zhao, et al.
Foilsithe / Cruthaithe: (2023-04-01)